v2.4.0.6
Business combinations (Details 1) (Biovex Group Inc [Member], USD $)
In Millions, unless otherwise specified
Mar. 04, 2011
Biovex Group Inc [Member]
 
Aggregate acquisition date consideration to acquire an entity  
Cash paid to former shareholders of acquired entity $ 407
Fair value of contingent consideration obligations 190
Total consideration 597
Allocation of the total consideration to the acquisition date fair values of assets acquired and liabilities assumed  
Indefinite-lived intangible assets--IPR&D 675
Goodwill 170
Deferred tax assets (liabilities), net (246)
Other assets (liabilities), net (2)
Total consideration $ 597